You can:
Name | D(1A) dopamine receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | DRD1 |
Synonym | D1 receptor D1A DADR Gpcr15 dopamine D1 receptor [ Show all ] |
Disease | Unspecified Hypertension Pain Parkinson's disease Psychiatric disorder [ Show all ] |
Length | 446 |
Amino acid sequence | MRTLNTSAMDGTGLVVERDFSVRILTACFLSLLILSTLLGNTLVCAAVIRFRHLRSKVTNFFVISLAVSDLLVAVLVMPWKAVAEIAGFWPFGSFCNIWVAFDIMCSTASILNLCVISVDRYWAISSPFRYERKMTPKAAFILISVAWTLSVLISFIPVQLSWHKAKPTSPSDGNATSLAETIDNCDSSLSRTYAISSSVISFYIPVAIMIVTYTRIYRIAQKQIRRIAALERAAVHAKNCQTTTGNGKPVECSQPESSFKMSFKRETKVLKTLSVIMGVFVCCWLPFFILNCILPFCGSGETQPFCIDSNTFDVFVWFGWANSSLNPIIYAFNADFRKAFSTLLGCYRLCPATNNAIETVSINNNGAAMFSSHHEPRGSISKECNLVYLIPHAVGSSEDLKKEEAAGIARPLEKLSPALSVILDYDTDVSLEKIQPITQNGQHPT |
UniProt | P21728 |
Protein Data Bank | N/A |
GPCR-HGmod model | P21728 |
3D structure model | This predicted structure model is from GPCR-EXP P21728. |
BioLiP | N/A |
Therapeutic Target Database | T22118 |
ChEMBL | CHEMBL2056 |
IUPHAR | 214 |
DrugBank | BE0000020 |
Name | CHEMBL213201 |
---|---|
Molecular formula | C26H23ClN6O |
IUPAC name | N-[8-chloro-6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzodiazepin-11-yl]-4-cyanobenzamide |
Molecular weight | 470.961 |
Hydrogen bond acceptor | 5 |
Hydrogen bond donor | 1 |
XlogP | 4.1 |
Synonyms | BDBM50190074 N-[2-chloro-11-(4-methyl-piperazin-1-yl)-dibenzo[b,e][1,4]diazepin-5-yl]-4-cyano-benzamide |
Inchi Key | AUKPHAAWNDZREH-UHFFFAOYSA-N |
Inchi ID | InChI=1S/C26H23ClN6O/c1-31-12-14-32(15-13-31)25-21-16-20(27)10-11-23(21)33(24-5-3-2-4-22(24)29-25)30-26(34)19-8-6-18(17-28)7-9-19/h2-11,16H,12-15H2,1H3,(H,30,34) |
PubChem CID | 44415743 |
ChEMBL | CHEMBL213201 |
IUPHAR | N/A |
BindingDB | 50190074 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand satisfies Lipinski's rule of five. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Ki | 64.0 nM | PMID16806922 | BindingDB,ChEMBL |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417